MENU
Heron Therapeutics (HRTX) Ownership - Who owns Heron Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
4242 Campus Point Court
Phone
+1 858 251-4400
Employees
126
Web
https://www.herontx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
273M
P/E Ratio
N/A
Total Cash
67.35M
Projected Growth
N/A
Total Debt
178.71M
Revenue
136.36M
Risk (Beta)
1.98
Dividend Yield
N/A
Total Cash/Share
0.44
Total Debt/Equity
N/A
Revenue/Share
0.88 USD as % of share price
Fundamentals
HRTX
Capitalization
273M
P/E Ratio
N/A
Risk (Beta)
1.98
Dividend Yield
N/A
Total Cash
67.3M
Total Cash/Share
0.44
Total Debt
179M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.88%
Revenue
136M
ROE
N/A
Book Value
-37.94M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.52M
Current Ratio
2.38
Current Revenue Per Employee
285904.75
Dividends Per Share - Security
N/A
EBITDA
-39.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
70.80
Revenue To Assets
-22.95
Shares Held By Institutions
539M
Shares Outstanding - Current
152M
Total Liabilities
256M
Total Volume MTD
N/A
Value
-1
Gain YTD
5.882
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of polymer technologies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4242 Campus Point Court
Phone
+1 858 251-4400
Employees
126
Web
https://www.herontx.com